Article
Mitochondrial dysfunction in myasthenia gravis: Exploring directions for future immunotherapy? A review
1 Oct 2024
Abstract excerpt
Myasthenia gravis (MG) is an acquired autoimmune disease characterized by impaired transmission at the neuromuscular junction, primarily manifesting as fluctuating muscle weakness, fatigability, and partial paralysis. Due to its long disease course, treatment resistance, and frequent relapses, it places a significant burden on patients and their families. In recent years, advances in molecular biology have...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
